Sylvia L. Asa

What is she best known for?

The fields of study she is best known for:

• Internal medicine
• Cancer
• Gene

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Pathology, Thyroid and Thyroid carcinoma. Her study looks at the relationship between Endocrinology and fields such as Gene expression, as well as how they intersect with chemical problems. The various areas that Sylvia L. Asa examines in her Pathology study include Gene rearrangement and Pituitary tumorigenesis.

Her Thyroid research is mostly focused on the topic Thyroid cancer. Her Thyroid carcinoma research incorporates elements of MEDLINE, Lymph node, Thyroidectomy, Carcinoma and Metastasis. Her Adenoma research is multidisciplinary, incorporating perspectives in Somatotropic cell, Estrogen receptor, Anterior pituitary, Acromegaly and Pituitary neoplasm.

Her most cited work include:

• Integrated Genomic Characterization of Papillary Thyroid Carcinoma (1325 citations)
• Revised American thyroid association guidelines for the management of medullary thyroid carcinoma (850 citations)
• The prevalence of pituitary adenomas: a systematic review. (815 citations)

What are the main themes of her work throughout her whole career to date?

Sylvia L. Asa mainly investigates Pathology, Internal medicine, Endocrinology, Thyroid and Immunohistochemistry. She usually deals with Pathology and limits it to topics linked to Thyroid carcinoma and Metastasis. Her Internal medicine study typically links adjacent topics like Oncology.

Her research on Endocrinology frequently links to adjacent areas such as Gene expression. Her Thyroid research is multidisciplinary, incorporating elements of Differential diagnosis, Cancer and Malignancy. Her work in Pituitary tumors tackles topics such as Cancer research which are related to areas like Fibroblast growth factor receptor 2 and Carcinogenesis.

She most often published in these fields:

• Pathology (62.45%)
• Internal medicine (41.18%)
• Endocrinology (36.61%)

What were the highlights of her more recent work (between 2017-2021)?

• Pathology (62.45%)
• Thyroid (29.21%)
• Neuroendocrine tumors (8.21%)

In recent papers she was focusing on the following fields of study:

Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Internal medicine are her primary areas of study. She interconnects Somatotropic cell and Endocrine pathology in the investigation of issues within Pathology. Her study in Thyroid carcinoma and Thyroid cancer is done as part of Thyroid.

Her Neuroendocrine tumors research is multidisciplinary, relying on both Pituitary carcinoma, Pituitary adenoma, Hormone, Corticotropic cell and Cushing Disease. Her Immunohistochemistry study integrates concerns from other disciplines, such as Cell type and Pathogenesis. Her research in Internal medicine intersects with topics in Gastroenterology, Endocrinology, Oncology and SDHB.

Between 2017 and 2021, her most popular works were:

• Pan-cancer analysis of whole genomes (538 citations)
• Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
• A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. (264 citations)

In her most recent research, the most cited papers focused on:

• Cancer
• Gene
• Internal medicine

Her primary scientific interests are in Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Cancer research. She combines subjects such as Human physiology, Thyroid carcinoma, MEDLINE and Endocrine pathology with her study of Pathology. Sylvia L. Asa has included themes like Cyst, Pheochromocytoma and Malignancy in her Thyroid study.

Her Neuroendocrine tumors study is concerned with the larger field of Internal medicine. Her Internal medicine research integrates issues from BRAF V600E and Histopathology. Her Immunohistochemistry research focuses on Somatotropic cell and how it relates to GATA3.